SUNZEN

Quarterly rpt on consolidated results for the financial period ended 30/6/2013

SUNZEN BIOTECH BERHAD

Financial Year End

31/12/2013
Quarter2
Quarterly report for the financial period ended30/06/2013
The figureshave not been audited
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2013

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2013
30/06/2012
30/06/2013
30/06/2012
$$'000
$$'000
$$'000
$$'000
1Revenue
8,553
7,947
16,727
16,100
2Profit/(loss) before tax
770
363
1,567
953
3Profit/(loss) for the period
645
240
1,313
659
4Profit/(loss) attributable to ordinary equity holders of the parent
645
240
1,313
659
5Basic earnings/(loss) per share (Subunit)
0.43
0.16
0.88
0.44
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.2100
0.2000
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NameSUNZEN BIOTECH BERHAD (ACE Market) 
Stock Name SUNZEN    
Date Announced28 Aug 2013  
CategoryFinancial Results
Reference NoCA-130826-63216